Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Process Optimization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel direct salting-out process reduces solvent residue and simplifies manufacturing for high-purity cephalosporin intermediates and APIs.
Novel solvent system enables direct filtration for LCZ696. Reduces impurities significantly. Ideal for pharmaceutical supply chains.
Patent CN107400118B reveals an optimized synthesis for esomeprazole intermediate mufelazole, offering improved purity and simplified workup for reliable pharma intermediates supply.
Discover the patented CN101362728A method for Valsartan synthesis featuring improved purity, safer azide handling, and cost-effective manufacturing processes for global supply chains.
Patent CN101410399A reveals a rapid isolation method for meropenem intermediates, offering significant cost reduction in carbapenem antibiotic manufacturing and improved supply chain reliability.
Patent CN109438351B details a high-yield, safe route for pentazocine intermediates, eliminating explosive reagents and high-pressure conditions for cost-effective manufacturing.
Novel crystallization method for biapenem intermediate ensures high purity and stability, offering supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN103102357B details a low-toxicity synthesis route for Cefuroxime sodium offering improved yield and stability for pharmaceutical supply chains.
Patent CN109280050B reveals a novel avanafil synthesis method offering high purity and cost reduction in pharmaceutical intermediates manufacturing through optimized oxidation steps.
Patent CN111056962A details a safe, column-free synthesis of Norspeltol and its acetate, eliminating hazardous azides for reliable pharmaceutical intermediate supply.
Patent CN112592347A details advanced control of isopropyl-substituted impurities in Tofacitinib synthesis, ensuring high-purity API manufacturing and optimized supply chain reliability.
Patent CN102936214B details a green synthesis of H acid using mother liquor recycling and hydrogenation, reducing waste by over 80% for reliable dye intermediate supply.
Advanced semi-synthetic route for Paclitaxel and Docetaxel offering high yield and purity. Optimized for cost reduction in API manufacturing and supply chain stability.